A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome

NCT00619164 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: E5555
DRUG: E5555
DRUG: E5555
DRUG: Placebo

Sponsor

Eisai Co., Ltd.